Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Export Certificates for FDA Regulated Products, 4147-4148 [E6-845]

Download as PDF Federal Register / Vol. 71, No. 16 / Wednesday, January 25, 2006 / Notices Dated: January 13, 2006. Jeffrey Shuren, Assistant Commissioner for Policy. [FR Doc. E6–844 Filed 1–24–06; 8:45 am] BILLING CODE 4160–01–S DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. 2005N–0190] Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Export Certificates for FDA Regulated Products AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995. DATES: Fax written comments on the collection of information by February 24, 2006. ADDRESSES: OMB is still experiencing significant delays in the regular mail, including first class and express mail, and messenger deliveries are not being accepted. To ensure that comments on the information collection are received, OMB recommends that written comments be faxed to the Office of Information and Regulatory Affairs, OMB, Attn: Fumie Yokota, Desk Officer for FDA, FAX: 202–395–6974. FOR FURTHER INFORMATION CONTACT: Jonna Capezzuto, Office of Management Programs (HFA–250), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301–827–4659. SUPPLEMENTARY INFORMATION: In compliance with 44 U.S.C. 3507, FDA has submitted the following proposed collection of information to OMB for review and clearance. Export of FDA Regulated Products— Export Certificates—(OMB Control Number 0910–0498)—Extension In April 1996, a law entitled ‘‘The FDA Export Reform and Enhancement Act of 1996’’ amended sections 801(e) and 802 of the act (21 U.S.C. 381(e) and 382). It was designed to ease restrictions on exportation of unapproved pharmaceuticals, biologics, and devices regulated by FDA. Section 801(e)(4) of the act provides that persons exporting certain FDA-regulated products may request that FDA certify that the products meet the requirements of sections 801(e) or 802 or other requirements of the act. This section of the law requires that FDA issue certification within 20 days of receipt of the request and charge firms up to $175 for the certifications. This section of the act authorizes FDA to issue export certificates for regulated 4147 pharmaceuticals, biologics, and devices that are legally marketed in the United States, as well as for pharmaceuticals, biologics, and devices that are not legally marketed, but are acceptable to the importing country as specified in sections 801(e) and 802 of the act. Section 801(e)(4) of the act provides that FDA shall, upon request, issue certificates for human drugs and biologics, animal drugs, and devices that either meet the applicable requirements of the act and may be legally marketed in the United States or may be legally exported under the act although they may not be legally marketed in the United States. The act does not require FDA to issue certificates for food, including animal feeds, food and feed additives, and dietary supplements, or cosmetics. However, because foreign governments may require certificates for these types of products, the agency intends to continue to provide this service as resources permit. FDA issues six types of certificates: (1) Certificate to Foreign Government (FDA 3613), (2) Certificate of Exportability (FDA 3613a), (3) Certificate of a Pharmaceutical Product (FDA 3613b), (4) Non-clinical Research Use Only Certificate (FDA 3613c), Office of Cosmetics and Colors ‘‘Certificate’’ (Exports) Application (FDA 3613d), and Food Export Certificate Application (FDA 3613e). Table 1 of this document lists the different certificates and details their uses: TABLE 1. LIST OF FDA EXPORT CERTIFICATES Form FDA Certificate Name Issuing FDA Center 3613 For the export of products that can be legally marketed in the United States. Center for Biologic Evaluation and Research (CBER); Center for Devices and Radiological Health (CDRH); Center for Veterinary Medicine (CVM) Certificate of Exportability 3613a For the export of products that cannot be legally marketed in the United States but meet the requirements of sections 801(e) or 802 of the act and may be legally exported. CBER; CDRH; CVM Certificate of a Pharmaceutical Product 3613b For use by the importing country when considering whether to license the product in question for sale in that country. Conforms to the format established by the World Health Organization. CBER; Center for Drug Evaluation and Research; CVM Non-Clinical Research Use Only Certificate wwhite on PROD1PC61 with NOTICES Certificate to Foreign Government Use 3613c For the export of non-clinical research use only product, material, component that is not intended for human use which may be marketed in, and legally exported from the United States under the act. CBER; CDRH Office of Cosmetics and Colors ‘‘Certificate’’ (Exports) Application 3613d For the export of products that are identified by the requester as cosmetics. Center for Food Safety and Applied Nutrition (CFSAN) VerDate Aug<31>2005 18:26 Jan 24, 2006 Jkt 208001 PO 00000 Frm 00049 Fmt 4703 Sfmt 4703 E:\FR\FM\25JAN1.SGM 25JAN1 4148 Federal Register / Vol. 71, No. 16 / Wednesday, January 25, 2006 / Notices TABLE 1. LIST OF FDA EXPORT CERTIFICATES—Continued Certificate Name Form FDA Food Export Certificate Application 3613e In the Federal Register of June 21, 2005 (70 FR 35678), FDA published a 60-day notice requesting public comment on the information collection provisions involving export certificates. FDA received three comments; however, only one was related to the information collection. The commenter suggested that extending the ‘‘Certificate to Foreign Government’’ 2-year expiration date to 3, 4 or 5 years would reduce their financial burden. The export certificate expiration date is based on the agency Use Issuing FDA Center For food products and dietary supplements that may be legally marketed in the United States. inspection schedule. At this time FDA is not considering reevaluating the inspection schedule. FDA will continue to rely on selfcertification by manufacturers for the first three types of certificates listed in Table 1 of this notice. Manufacturers are requested to self-certify that they are in compliance with all applicable requirements of the act, not only at the time that they submit their request to the appropriate center, but also at the time that they submit the certification to the foreign government. CFSAN The appropriate FDA centers will review product information submitted by firms in support of their certificate and any suspected case of fraud will be referred to FDA’s Office of Criminal Investigations for follow-up. Firms making or submitting to FDA false statements on any documents may constitute violations of 18 U.S.C. 1001, with penalties including up to $250,000 in fines and up to 5 years imprisonment. FDA estimates the burden of this collection of information as follows: TABLE 2.—ESTIMATED ANNUAL REPORTING BURDEN1 No. of respondents FDA Center Annual frequency per response Total annual responses Hours per response Total hours CBER 1,501 1 1,501 1 1,501 CDER 4,803 1 4,803 1 4,803 CDRH 5,674 1 5,674 22 11,348 CFSAN, Office of Cosmetics and Colors 730 1 730 1 730 CFSAN, Office of Plant and Dairy Foods 181 1 181 1.5 271.5 CFSAN, Office of Nutritional Products, Labeling and Dietary Supplements 660 1 660 1.5 990 CFSAN, Office of Seafood 575 1 575 1.5 862.5 CVM 664 1 664 1 664 Total 21,170 1 There are no capital costs or operating and maintenance costs associated with this collection of information. 2 Based on center policy that allows multiple devices to appear on one certificate. Dated: January 13, 2006. Jeffrey Shuren, Assistant Commissioner for Policy. [FR Doc. E6–845 Filed 1–24–06; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES BILLING CODE 4160–01–S [Docket No. 2006D–0011] Food and Drug Administration wwhite on PROD1PC61 with NOTICES Global Harmonization Task Force, Study Groups 1, 2, 3, and 4; New Proposed and Final Documents; Availability AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration (FDA) is announcing the VerDate Aug<31>2005 18:26 Jan 24, 2006 Jkt 208001 PO 00000 Frm 00050 Fmt 4703 Sfmt 4703 availability of several proposed and final documents that have been prepared by Study Groups 1, 2, 3, and 4 of the Global Harmonization Task Force (GHTF). These documents are intended to provide information only and represent a harmonized proposal and recommendation from the GHTF Study Groups that may be used by governments developing and updating their regulatory requirements for medical devices. These documents are intended to provide information only and do not describe current regulatory requirements; elements of these documents may not be consistent with current U.S. regulatory requirements. E:\FR\FM\25JAN1.SGM 25JAN1

Agencies

[Federal Register Volume 71, Number 16 (Wednesday, January 25, 2006)]
[Notices]
[Pages 4147-4148]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-845]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. 2005N-0190]


Agency Information Collection Activities; Submission for Office 
of Management and Budget Review; Comment Request; Export Certificates 
for FDA Regulated Products

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing that a 
proposed collection of information has been submitted to the Office of 
Management and Budget (OMB) for review and clearance under the 
Paperwork Reduction Act of 1995.

DATES: Fax written comments on the collection of information by 
February 24, 2006.

ADDRESSES: OMB is still experiencing significant delays in the regular 
mail, including first class and express mail, and messenger deliveries 
are not being accepted. To ensure that comments on the information 
collection are received, OMB recommends that written comments be faxed 
to the Office of Information and Regulatory Affairs, OMB, Attn: Fumie 
Yokota, Desk Officer for FDA, FAX: 202-395-6974.

FOR FURTHER INFORMATION CONTACT: Jonna Capezzuto, Office of Management 
Programs (HFA-250), Food and Drug Administration, 5600 Fishers Lane, 
Rockville, MD 20857, 301-827-4659.

SUPPLEMENTARY INFORMATION: In compliance with 44 U.S.C. 3507, FDA has 
submitted the following proposed collection of information to OMB for 
review and clearance.

Export of FDA Regulated Products--Export Certificates--(OMB Control 
Number 0910-0498)--Extension

    In April 1996, a law entitled ``The FDA Export Reform and 
Enhancement Act of 1996'' amended sections 801(e) and 802 of the act 
(21 U.S.C. 381(e) and 382). It was designed to ease restrictions on 
exportation of unapproved pharmaceuticals, biologics, and devices 
regulated by FDA. Section 801(e)(4) of the act provides that persons 
exporting certain FDA-regulated products may request that FDA certify 
that the products meet the requirements of sections 801(e) or 802 or 
other requirements of the act. This section of the law requires that 
FDA issue certification within 20 days of receipt of the request and 
charge firms up to $175 for the certifications.
    This section of the act authorizes FDA to issue export certificates 
for regulated pharmaceuticals, biologics, and devices that are legally 
marketed in the United States, as well as for pharmaceuticals, 
biologics, and devices that are not legally marketed, but are 
acceptable to the importing country as specified in sections 801(e) and 
802 of the act. Section 801(e)(4) of the act provides that FDA shall, 
upon request, issue certificates for human drugs and biologics, animal 
drugs, and devices that either meet the applicable requirements of the 
act and may be legally marketed in the United States or may be legally 
exported under the act although they may not be legally marketed in the 
United States. The act does not require FDA to issue certificates for 
food, including animal feeds, food and feed additives, and dietary 
supplements, or cosmetics. However, because foreign governments may 
require certificates for these types of products, the agency intends to 
continue to provide this service as resources permit. FDA issues six 
types of certificates: (1) Certificate to Foreign Government (FDA 
3613), (2) Certificate of Exportability (FDA 3613a), (3) Certificate of 
a Pharmaceutical Product (FDA 3613b), (4) Non-clinical Research Use 
Only Certificate (FDA 3613c), Office of Cosmetics and Colors 
``Certificate'' (Exports) Application (FDA 3613d), and Food Export 
Certificate Application (FDA 3613e). Table 1 of this document lists the 
different certificates and details their uses:

                Table 1. List of FDA Export Certificates
------------------------------------------------------------------------
                       Form
  Certificate Name     FDA             Use           Issuing FDA Center
------------------------------------------------------------------------
Certificate to          3613  For the export of     Center for Biologic
 Foreign Government            products that can     Evaluation and
                               be legally marketed   Research (CBER);
                               in the United         Center for Devices
                               States.               and Radiological
                                                     Health (CDRH);
                                                     Center for
                                                     Veterinary Medicine
                                                     (CVM)
------------------------------------------------------------------------
Certificate of         3613a  For the export of     CBER; CDRH; CVM
 Exportability                 products that
                               cannot be legally
                               marketed in the
                               United States but
                               meet the
                               requirements of
                               sections 801(e) or
                               802 of the act and
                               may be legally
                               exported.
------------------------------------------------------------------------
Certificate of a       3613b  For use by the        CBER; Center for
 Pharmaceutical                importing country     Drug Evaluation and
 Product                       when considering      Research; CVM
                               whether to license
                               the product in
                               question for sale
                               in that country.
                               Conforms to the
                               format established
                               by the World Health
                               Organization.
------------------------------------------------------------------------
Non-Clinical           3613c  For the export of     CBER; CDRH
 Research Use Only             non-clinical
 Certificate                   research use only
                               product, material,
                               component that is
                               not intended for
                               human use which may
                               be marketed in, and
                               legally exported
                               from the United
                               States under the
                               act.
------------------------------------------------------------------------
Office of Cosmetics    3613d  For the export of     Center for Food
 and Colors                    products that are     Safety and Applied
 ``Certificate''               identified by the     Nutrition (CFSAN)
 (Exports)                     requester as
 Application                   cosmetics.
------------------------------------------------------------------------

[[Page 4148]]

 
Food Export            3613e  For food products     CFSAN
 Certificate                   and dietary
 Application                   supplements that
                               may be legally
                               marketed in the
                               United States.
------------------------------------------------------------------------

    In the Federal Register of June 21, 2005 (70 FR 35678), FDA 
published a 60-day notice requesting public comment on the information 
collection provisions involving export certificates. FDA received three 
comments; however, only one was related to the information collection.
    The commenter suggested that extending the ``Certificate to Foreign 
Government'' 2-year expiration date to 3, 4 or 5 years would reduce 
their financial burden. The export certificate expiration date is based 
on the agency inspection schedule. At this time FDA is not considering 
reevaluating the inspection schedule.
    FDA will continue to rely on self-certification by manufacturers 
for the first three types of certificates listed in Table 1 of this 
notice. Manufacturers are requested to self-certify that they are in 
compliance with all applicable requirements of the act, not only at the 
time that they submit their request to the appropriate center, but also 
at the time that they submit the certification to the foreign 
government.
    The appropriate FDA centers will review product information 
submitted by firms in support of their certificate and any suspected 
case of fraud will be referred to FDA's Office of Criminal 
Investigations for follow-up. Firms making or submitting to FDA false 
statements on any documents may constitute violations of 18 U.S.C. 
1001, with penalties including up to $250,000 in fines and up to 5 
years imprisonment.
    FDA estimates the burden of this collection of information as 
follows:

                                                     Table 2.--Estimated Annual Reporting Burden\1\
--------------------------------------------------------------------------------------------------------------------------------------------------------
                                                              No. of         Annual frequency       Total annual        Hours per
                      FDA Center                           respondents         per response          responses           response         Total hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
CBER                                                                1,501                     1              1,501                  1              1,501
--------------------------------------------------------------------------------------------------------------------------------------------------------
CDER                                                                4,803                     1              4,803                  1              4,803
--------------------------------------------------------------------------------------------------------------------------------------------------------
CDRH                                                                5,674                     1              5,674               2\2\             11,348
--------------------------------------------------------------------------------------------------------------------------------------------------------
CFSAN, Office of Cosmetics and Colors                                 730                     1                730                  1                730
--------------------------------------------------------------------------------------------------------------------------------------------------------
CFSAN, Office of Plant and Dairy Foods                                181                     1                181                1.5              271.5
--------------------------------------------------------------------------------------------------------------------------------------------------------
CFSAN, Office of Nutritional Products, Labeling and                   660                     1                660                1.5                990
 Dietary Supplements
--------------------------------------------------------------------------------------------------------------------------------------------------------
CFSAN, Office of Seafood                                              575                     1                575                1.5              862.5
--------------------------------------------------------------------------------------------------------------------------------------------------------
CVM                                                                   664                     1                664                  1                664
--------------------------------------------------------------------------------------------------------------------------------------------------------
Total                                                                                                                                             21,170
--------------------------------------------------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of information.
\2\ Based on center policy that allows multiple devices to appear on one certificate.


    Dated: January 13, 2006.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. E6-845 Filed 1-24-06; 8:45 am]
BILLING CODE 4160-01-S
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.